AxoGen, Inc.
AXGN
$17.69
-$0.12-0.67%
| Weiss Ratings | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.87 | |||
| Price History | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.53% | |||
| 30-Day Total Return | -5.30% | |||
| 60-Day Total Return | 9.81% | |||
| 90-Day Total Return | 38.75% | |||
| Year to Date Total Return | 7.87% | |||
| 1-Year Total Return | 126.50% | |||
| 2-Year Total Return | 88.19% | |||
| 3-Year Total Return | 115.21% | |||
| 5-Year Total Return | 113.91% | |||
| 52-Week High % Change | -15.19% | |||
| 52-Week Low % Change | 220.90% | |||
| Price | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $21.00 | |||
| 52-Week Low Price | $5.55 | |||
| 52-Week Low Price (Date) | May 06, 2024 | |||
| 52-Week High Price (Date) | Feb 25, 2025 | |||
| Valuation | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 789.76M | |||
| Enterprise Value | 827.37M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.23 | |||
| Earnings Per Share Growth | -55.86% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.57 | |||
| Price/Book (Q) | 7.57 | |||
| Enterprise Value/Revenue (TTM) | 4.42 | |||
| Price | $17.69 | |||
| Enterprise Value/EBITDA (TTM) | 240.03 | |||
| Enterprise Value/EBIT | -251.71 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 48.06M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 386 462 6800 | |||
| Address | 13631 Progress Boulevard Alachua, FL 32615 | |||
| Website | www.axogeninc.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1.75% | |||
| Profit Margin | -5.31% | |||
| Management Effectiveness | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.03% | |||
| Return on Equity | -- | |||
| Income Statement | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 187.34M | |||
| Total Revenue (TTM) | 187.34M | |||
| Revenue Per Share | $3.90 | |||
| Gross Profit (TTM) | 141.98M | |||
| EBITDA (TTM) | 3.45M | |||
| EBIT (TTM) | -3.29M | |||
| Net Income (TTM) | -9.96M | |||
| Net Income Avl. to Common (TTM) | -9.96M | |||
| Total Revenue Growth (Q YOY) | 15.10% | |||
| Earnings Growth (Q YOY) | 111.56% | |||
| EPS Diluted (TTM) | -0.23 | |||
| EPS Diluted Growth (Q YOY) | 111.06% | |||
| Balance Sheet | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 33.48M | |||
| Cash Per Share (Q) | $0.70 | |||
| Total Current Assets (Q) | 99.22M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 103.91M | |||
| Current Ratio (Q) | 3.241 | |||
| Book Value Per Share (Q) | $2.35 | |||
| Total Assets (Q) | 203.73M | |||
| Total Current Liabilities (Q) | 30.61M | |||
| Total Debt (Q) | 71.09M | |||
| Total Liabilities (Q) | 99.82M | |||
| Total Common Equity (Q) | 103.91M | |||
| Cash Flow | AXGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -10.30M | |||
| Cash from Financing (TTM) | 2.29M | |||
| Net Change in Cash (TTM) | -3.47M | |||
| Levered Free Cash Flow (TTM) | 3.93M | |||
| Cash from Operations (TTM) | 4.54M | |||
